British household goods firm Reckitt Benckiser warned on Tuesday that annual sales would be towards the lower end of forecasts, after a weaker-than-expected third-quarter performance.
The group, which produces Durex condoms, household cleaner Cillit Bang, and Nurofen pain relief tablets, revealed the news in a results statement.
Reckitt added that revenues slid seven percent to £2.37 billion ($3.8 billion, 3.0 billion euros) in the third quarter of the year, compared with the same part of 2013.
"Looking ahead, our objective remains to deliver growth which outperforms our markets, although conditions will remain challenging," said Reckitt chief executive Rakesh Kapoor.
"I continue to expect that the strength of our brands and the quality of our innovations will deliver our full year revenue targets, at the lower end of the range of 4.0-5.0 percent."